Download presentation
Presentation is loading. Please wait.
Published byMarylou Horton Modified over 6 years ago
1
Copyright © 2002 American Medical Association. All rights reserved.
From: Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA. 2002;288(20): doi: /jama Figure Legend: AGE indicates advanced glycation endproduct; oxLDL, oxidized low-densitylipoprotein; GSH, glutathione; GSSG, glutathione disulfide; and NADPH, nicotinamide-adeninedinucleotide phosphate. Date of download: 10/11/2017 Copyright © 2002 American Medical Association. All rights reserved.
2
Copyright © 2002 American Medical Association. All rights reserved.
From: Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA. 2002;288(20): doi: /jama Date of download: 10/11/2017 Copyright © 2002 American Medical Association. All rights reserved.
3
Copyright © 2002 American Medical Association. All rights reserved.
From: Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA. 2002;288(20): doi: /jama Figure Legend: NADPH indicates reduced nicotinamide-adenine dinucleotide phosphate;NADP+, oxidized nicotinamide-adenine dinucleotide phosphate; NAD+, oxidized nicotinamide adenine dinucleotide; and NADH, reduced nicotinamideadenine dinucleotide. Date of download: 10/11/2017 Copyright © 2002 American Medical Association. All rights reserved.
4
Copyright © 2002 American Medical Association. All rights reserved.
From: Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA. 2002;288(20): doi: /jama Figure Legend: AR indicates aldose reductase; RAGE, receptor for advanced glycationendproducts; PKC, protein kinase C. Date of download: 10/11/2017 Copyright © 2002 American Medical Association. All rights reserved.
5
Copyright © 2002 American Medical Association. All rights reserved.
From: Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA. 2002;288(20): doi: /jama Figure Legend: OXPHOS indicates oxidative phosphorylation; ROI, reactive oxygenintermediate; AGE, advanced glycation endproduct; and NADPH, nicotinamide-adeninedinucleotide phosphate. Date of download: 10/11/2017 Copyright © 2002 American Medical Association. All rights reserved.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.